Catalyst Wire Dossier Catalyst Wire Dossier

131I-huA33

131I-huA33
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 131I-huA33, covering 2022-01-11 to 2022-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer [Phase 1]

See pricing